Latest Revenue Guidance News

Ava Risk Group reports a positive EBITDA turnaround for FY2025 despite missing revenue guidance due to delayed key orders. The company highlights strong momentum in telecommunications and aviation sectors with promising technology deployments.

Hansen Technologies has raised its FY25 profitability outlook, driven by operational efficiencies and early powercloud profits, despite a slight revenue timing shift. The company also secured major new contracts across Europe and the US.

Change Financial has surpassed its FY25 revenue targets and is set to report its first positive underlying EBITDA, signaling a pivotal shift for the fintech. The company also projects strong revenue and earnings growth for FY26, underpinned by robust sales momentum and operational efficiencies.

SciDev Limited has secured $21.5 million in new contracts and renewals across oil & gas, mining, and PFAS remediation sectors, boosting its FY26 revenue guidance to $120-$140 million.

GenusPlus Group has secured a significant maintenance and upgrade contract with Western Power, expected to generate around $65 million in revenue for FY2026, reinforcing its role in Western Australia's electricity infrastructure.

Electro Optic Systems projects first-half 2025 revenue between A$40 million and A$45 million, underpinned by a major Middle East contract and a growing contract backlog now at A$170 million.

PointsBet Holdings Limited has updated its FY25 financial outlook, signalling that both revenue and EBITDA are expected to land at the bottom of previously forecasted ranges.

DXN Limited has secured a $1.6 million contract with Ventia to deploy its innovative StructCore prefabricated indoor data centre solution for a major Australian telecommunications provider, marking a strategic expansion into a new market segment.

Cogstate Ltd has upgraded its FY25 financial guidance, projecting a 20-24% revenue increase and nearly doubling profit before tax compared to last year.

Microba Life Sciences announces a $12.5 million equity raise, including a strategic $8.3 million investment from Sonic Healthcare, aiming to fuel growth in the UK and achieve regional break-even by FY26.

Microba Life Sciences has raised $14.5 million to accelerate clinical adoption of its microbiome testing products, while narrowing its FY25 revenue guidance and signing a strategic UK laboratory agreement.

Amaero has completed commissioning its second advanced atomizer at its Tennessee facility, reinforcing its production capacity and reaffirming strong revenue visibility for FY2026. The company’s strategic investments position it as a key domestic supplier in the US advanced manufacturing sector.